DexCom's Revenue
- DexCom's annual revenue was $4.66 B in fiscal year 2025. The annual revenue increased $629.00 M from $4.03 B (in 2024) to $4.66 B (in 2025), representing a 15.60% year-over-year growth.
- DexCom's quarterly revenue was $1.26 B in the quarter ending Dec 2025. The quarterly revenue increased $146.10 M from $1.11 B (in Q4: Sept 2024) to $1.26 B (in Q4: Sept 2025), representing a 13.12% year-over-year growth.
- The highest annual revenue for DexCom was $4.66 B in fiscal year 2025.
- The lowest annual revenue was $573.30 M in fiscal year 2016.
- The average revenue was $2.34 B.
- Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2016 - 2025):
Learn more about DexCom's Revenue by Segment and Revenue by Region.
Check out competitors to DexCom in a side-by-side comparison.
Explore additional financial metrics for DexCom.
Definition of Revenue :
DexCom's Revenue Trend
| 2015 | 402000000.00 |
|---|---|
| 2016 | 573300000.00 |
| 2017 | 718500000.00 |
| 2018 | 1031600000.00 |
| 2019 | 1476000000.00 |
| 2020 | 1926700000.00 |
| 2021 | 2448500000.00 |
| 2022 | 2909800000.00 |
| 2023 | 3622300000.00 |
| 2024 | 4033000000.00 |
| 2025 | 4662000000.00 |
| Mar 2016 | 116200000.00 |
|---|---|
| Jun 2016 | 137300000.00 |
| Sep 2016 | 148600000.00 |
| Dec 2016 | 171200000.00 |
| Mar 2017 | 142300000.00 |
| Jun 2017 | 170600000.00 |
| Sep 2017 | 184600000.00 |
| Dec 2017 | 221000000.00 |
| Mar 2018 | 184400000.00 |
| Jun 2018 | 242500000.00 |
| Sep 2018 | 266700000.00 |
| Dec 2018 | 338000000.00 |
| Mar 2019 | 280500000.00 |
| Jun 2019 | 336400000.00 |
| Sep 2019 | 396300000.00 |
| Dec 2019 | 462800000.00 |
| Mar 2020 | 405100000.00 |
| Jun 2020 | 451800000.00 |
| Sep 2020 | 500900000.00 |
| Dec 2020 | 568900000.00 |
| Mar 2021 | 505000000.00 |
| Jun 2021 | 595100000.00 |
| Sep 2021 | 650200000.00 |
| Dec 2021 | 698200000.00 |
| Mar 2022 | 628800000.00 |
| Jun 2022 | 696200000.00 |
| Sep 2022 | 769600000.00 |
| Dec 2022 | 815200000.00 |
| Mar 2023 | 741500000.00 |
| Jun 2023 | 871300000.00 |
| Sep 2023 | 975000000.00 |
| Dec 2023 | 1034500000.00 |
| Mar 2024 | 921000000.00 |
| Jun 2024 | 1004300000.00 |
| Sep 2024 | 994200000.00 |
| Dec 2024 | 1113500000.00 |
| Mar 2025 | 1036000000.00 |
| Jun 2025 | 1157100000.00 |
| Sep 2025 | 1209300000.00 |
| Dec 2025 | 1259600000.00 |
2025
DexCom's annual revenue was $4.66 B in fiscal year 2025.
DexCom's quarterly revenue was $1.04 B(Q1: Mar 2025), $1.16 B(Q2: Jun 2025), $1.21 B(Q3: Sep 2025), $1.26 B(Q4: Dec 2025) in fiscal year 2025.
2024
DexCom's annual revenue was $4.03 B in fiscal year 2024.
DexCom's quarterly revenue was $921.00 M(Q1: Mar 2024), $1.00 B(Q2: Jun 2024), $994.20 M(Q3: Sep 2024), $1.11 B(Q4: Dec 2024) in fiscal year 2024.
2023
DexCom's annual revenue was $3.62 B in fiscal year 2023.
DexCom's quarterly revenue was $741.50 M(Q1: Mar 2023), $871.30 M(Q2: Jun 2023), $975.00 M(Q3: Sep 2023), $1.03 B(Q4: Dec 2023) in fiscal year 2023.
2022
DexCom's annual revenue was $2.91 B in fiscal year 2022.
DexCom's quarterly revenue was $628.80 M(Q1: Mar 2022), $696.20 M(Q2: Jun 2022), $769.60 M(Q3: Sep 2022), $815.20 M(Q4: Dec 2022) in fiscal year 2022.
2021
DexCom's annual revenue was $2.45 B in fiscal year 2021.
DexCom's quarterly revenue was $505.00 M(Q1: Mar 2021), $595.10 M(Q2: Jun 2021), $650.20 M(Q3: Sep 2021), $698.20 M(Q4: Dec 2021) in fiscal year 2021.
2020
DexCom's annual revenue was $1.93 B in fiscal year 2020.
DexCom's quarterly revenue was $405.10 M(Q1: Mar 2020), $451.80 M(Q2: Jun 2020), $500.90 M(Q3: Sep 2020), $568.90 M(Q4: Dec 2020) in fiscal year 2020.
2019
DexCom's annual revenue was $1.48 B in fiscal year 2019.
DexCom's quarterly revenue was $280.50 M(Q1: Mar 2019), $336.40 M(Q2: Jun 2019), $396.30 M(Q3: Sep 2019), $462.80 M(Q4: Dec 2019) in fiscal year 2019.
2018
DexCom's annual revenue was $1.03 B in fiscal year 2018.
DexCom's quarterly revenue was $184.40 M(Q1: Mar 2018), $242.50 M(Q2: Jun 2018), $266.70 M(Q3: Sep 2018), $338.00 M(Q4: Dec 2018) in fiscal year 2018.
2017
DexCom's annual revenue was $718.50 M in fiscal year 2017.
DexCom's quarterly revenue was $142.30 M(Q1: Mar 2017), $170.60 M(Q2: Jun 2017), $184.60 M(Q3: Sep 2017), $221.00 M(Q4: Dec 2017) in fiscal year 2017.
2016
DexCom's annual revenue was $573.30 M in fiscal year 2016.
DexCom's quarterly revenue was $116.20 M(Q1: Mar 2016), $137.30 M(Q2: Jun 2016), $148.60 M(Q3: Sep 2016), $171.20 M(Q4: Dec 2016) in fiscal year 2016.
DexCom's Revenue (Year-over-Year Change)
| 2015 | 0 |
|---|---|
| 2016 | +42.61 |
| 2017 | +25.33 |
| 2018 | +43.58 |
| 2019 | +43.08 |
| 2020 | +30.54 |
| 2021 | +27.08 |
| 2022 | +18.84 |
| 2023 | +24.49 |
| 2024 | +11.34 |
| 2025 | +15.60 |
| Q1: Mar 16 | 59.62 |
|---|---|
| Q2: Jun 16 | 47.32 |
| Q3: Sep 16 | 41.25 |
| Q4: Dec 16 | 30.89 |
| Q1: Mar 17 | 22.46 |
| Q2: Jun 17 | 24.25 |
| Q3: Sep 17 | 24.23 |
| Q4: Dec 17 | 29.09 |
| Q1: Mar 18 | 29.59 |
| Q2: Jun 18 | 42.15 |
| Q3: Sep 18 | 44.47 |
| Q4: Dec 18 | 52.94 |
| Q1: Mar 19 | 52.11 |
| Q2: Jun 19 | 38.72 |
| Q3: Sep 19 | 48.59 |
| Q4: Dec 19 | 36.92 |
| Q1: Mar 20 | 44.42 |
| Q2: Jun 20 | 34.30 |
| Q3: Sep 20 | 26.39 |
| Q4: Dec 20 | 22.93 |
| Q1: Mar 21 | 24.66 |
| Q2: Jun 21 | 31.72 |
| Q3: Sep 21 | 29.81 |
| Q4: Dec 21 | 22.73 |
| Q1: Mar 22 | 24.51 |
| Q2: Jun 22 | 16.99 |
| Q3: Sep 22 | 18.36 |
| Q4: Dec 22 | 16.76 |
| Q1: Mar 23 | 17.92 |
| Q2: Jun 23 | 25.15 |
| Q3: Sep 23 | 26.69 |
| Q4: Dec 23 | 26.90 |
| Q1: Mar 24 | 24.21 |
| Q2: Jun 24 | 15.26 |
| Q3: Sep 24 | 1.97 |
| Q4: Dec 24 | 7.64 |
| Q1: Mar 25 | 12.49 |
| Q2: Jun 25 | 15.21 |
| Q3: Sep 25 | 21.64 |
| Q4: Dec 25 | 13.12 |
2025
DexCom’s annual revenue increased +15.60% during fiscal year 2025 compared to 2024. It represents a growth of $629.00 M from $4.03 B (in 2024) to $4.66 B (in 2025).
2024
DexCom’s annual revenue increased +11.34% during fiscal year 2024 compared to 2023. It represents a growth of $410.70 M from $3.62 B (in 2023) to $4.03 B (in 2024).
2023
DexCom’s annual revenue increased +24.49% during fiscal year 2023 compared to 2022. It represents a growth of $712.50 M from $2.91 B (in 2022) to $3.62 B (in 2023).
2022
DexCom’s annual revenue increased +18.84% during fiscal year 2022 compared to 2021. It represents a growth of $461.30 M from $2.45 B (in 2021) to $2.91 B (in 2022).
2021
DexCom’s annual revenue increased +27.08% during fiscal year 2021 compared to 2020. It represents a growth of $521.80 M from $1.93 B (in 2020) to $2.45 B (in 2021).
2020
DexCom’s annual revenue increased +30.54% during fiscal year 2020 compared to 2019. It represents a growth of $450.70 M from $1.48 B (in 2019) to $1.93 B (in 2020).
2019
DexCom’s annual revenue increased +43.08% during fiscal year 2019 compared to 2018. It represents a growth of $444.40 M from $1.03 B (in 2018) to $1.48 B (in 2019).
2018
DexCom’s annual revenue increased +43.58% during fiscal year 2018 compared to 2017. It represents a growth of $313.10 M from $718.50 M (in 2017) to $1.03 B (in 2018).
2017
DexCom’s annual revenue increased +25.33% during fiscal year 2017 compared to 2016. It represents a growth of $145.20 M from $573.30 M (in 2016) to $718.50 M (in 2017).
2016
DexCom’s annual revenue increased +42.61% during fiscal year 2016 compared to 2015. It represents a growth of $171.30 M from $402.00 M (in 2015) to $573.30 M (in 2016).
Summary Table (Annual)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| 2025 | $4.66 B | +15.60% |
| 2024 | $4.03 B | +11.34% |
| 2023 | $3.62 B | +24.49% |
| 2022 | $2.91 B | +18.84% |
| 2021 | $2.45 B | +27.08% |
| 2020 | $1.93 B | +30.54% |
| 2019 | $1.48 B | +43.08% |
| 2018 | $1.03 B | +43.58% |
| 2017 | $718.50 M | +25.33% |
| 2016 | $573.30 M | +42.61% |
Summary Table (Quarterly)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| Q4: Dec 25 | $1.26 B | 13.12% |
| Q3: Sep 25 | $1.21 B | 21.64% |
| Q2: Jun 25 | $1.16 B | 15.21% |
| Q1: Mar 25 | $1.04 B | 12.49% |
| Q4: Dec 24 | $1.11 B | 7.64% |
| Q3: Sep 24 | $994.20 M | 1.97% |
| Q2: Jun 24 | $1.00 B | 15.26% |
| Q1: Mar 24 | $921.00 M | 24.21% |
| Q4: Dec 23 | $1.03 B | 26.90% |
| Q3: Sep 23 | $975.00 M | 26.69% |
| Q2: Jun 23 | $871.30 M | 25.15% |
| Q1: Mar 23 | $741.50 M | 17.92% |
| Q4: Dec 22 | $815.20 M | 16.76% |
| Q3: Sep 22 | $769.60 M | 18.36% |
| Q2: Jun 22 | $696.20 M | 16.99% |
| Q1: Mar 22 | $628.80 M | 24.51% |
| Q4: Dec 21 | $698.20 M | 22.73% |
| Q3: Sep 21 | $650.20 M | 29.81% |
| Q2: Jun 21 | $595.10 M | 31.72% |
| Q1: Mar 21 | $505.00 M | 24.66% |
| Q4: Dec 20 | $568.90 M | 22.93% |
| Q3: Sep 20 | $500.90 M | 26.39% |
| Q2: Jun 20 | $451.80 M | 34.30% |
| Q1: Mar 20 | $405.10 M | 44.42% |
| Q4: Dec 19 | $462.80 M | 36.92% |
| Q3: Sep 19 | $396.30 M | 48.59% |
| Q2: Jun 19 | $336.40 M | 38.72% |
| Q1: Mar 19 | $280.50 M | 52.11% |
| Q4: Dec 18 | $338.00 M | 52.94% |
| Q3: Sep 18 | $266.70 M | 44.47% |
| Q2: Jun 18 | $242.50 M | 42.15% |
| Q1: Mar 18 | $184.40 M | 29.59% |
| Q4: Dec 17 | $221.00 M | 29.09% |
| Q3: Sep 17 | $184.60 M | 24.23% |
| Q2: Jun 17 | $170.60 M | 24.25% |
| Q1: Mar 17 | $142.30 M | 22.46% |
| Q4: Dec 16 | $171.20 M | 30.89% |
| Q3: Sep 16 | $148.60 M | 41.25% |
| Q2: Jun 16 | $137.30 M | 47.32% |
| Q1: Mar 16 | $116.20 M | 59.62% |
